|
|
|
Volumn 2, Issue 2, 1995, Pages 125-136
|
|
Genetically marking human cells--results of the first clinical gene transfer studies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOKINE;
HYBRID PROTEIN;
KANAMYCIN KINASE;
PHOSPHOTRANSFERASE;
ADOPTIVE IMMUNOTHERAPY;
ANIMAL;
BIOSYNTHESIS;
BONE MARROW TRANSPLANTATION;
CELL MOTION;
CLINICAL TRIAL;
DRUG RESISTANCE;
GENE THERAPY;
GENE VECTOR;
GENETIC ENGINEERING;
GENETIC MARKER;
GENETIC TRANSFECTION;
GENETICS;
HUMAN;
MOUSE;
NEOPLASM;
PATHOLOGY;
PRIMATE;
RETROVIRUS;
REVIEW;
SAFETY;
TRANSPLANTATION;
TUMOR ASSOCIATED LEUKOCYTE;
ANIMALS;
BONE MARROW TRANSPLANTATION;
CELL MOVEMENT;
CLINICAL TRIALS;
CYTOKINES;
DRUG RESISTANCE;
GENE THERAPY;
GENETIC ENGINEERING;
GENETIC MARKERS;
GENETIC VECTORS;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
KANAMYCIN KINASE;
LYMPHOCYTES, TUMOR-INFILTRATING;
MICE;
NEOPLASMS;
PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);
PRIMATES;
RECOMBINANT FUSION PROTEINS;
RETROVIRIDAE;
SAFETY;
TRANSFECTION;
|
|
EID: 0029320345
PISSN: 09291903
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (25)
|
|
References (64)
|
